ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2161 - 2175 of 5508 products
HuaSin In-licenses China Rights to HPV Diagnostic from Spain's Genomica
$5.00
Available
Owlstone to Test Breath Biopsy Diagnostic at Shanghai Renji Hospital
$5.00
Available
GenomePrecision Raises $15 Million for Molecular Diagnostics
$5.00
Available
HaiHe Pharma Forms Drug Development/Marketing JV with CSPC
$5.00
Available
Suzhou's CStone Pharma Schedules $304 Million Hong Kong IPO for Next Week
$5.00
Available
Burning Rock of Guangzhou Raises $126 Million for NGS Diagnostics
$5.00
Available
Bioheng Closes $15 Million Funding from Decheng Capital for CAR-T Products
$5.00
Available
Magpie Guangzhou Pharma Completes $15 Million B Round
$5.00
Available
Ascletis Acquires Rights to 3-V Bio's NASH Candidate and Leads $18 Million E Financing
$5.00
Available
Shanghai HaiHe Raises $146.6 Million for Innovative Cancer Drugs
$5.00
Available
China Cuts Value Added Tax on Rare Disease Drugs to 3%
$5.00
Available
C-Bridge In-Licenses China Rights to Three Samsung Bioepis Biosimilars
$5.00
Available
3SBio Forms China Partnership with Verseau for Macrophage Checkpoint Modulators
$5.00
Available
China Resources Launches $300 Million Life Science Fund
$5.00
Available
China to Review IND Filing for CStone/Impact PD-L1/PARP Combo
$5.00
Available